TD Cowen Begins Coverage on Anteris Technologies Global (NASDAQ:AVR)

Equities researchers at TD Cowen assumed coverage on shares of Anteris Technologies Global (NASDAQ:AVR) in a report released on Tuesday, MarketBeat reports. The firm set a “buy” rating and a $15.00 price target on the stock. TD Cowen’s target price suggests a potential upside of 166.43% from the stock’s previous close.

Other analysts also recently issued research reports about the stock. Cantor Fitzgerald started coverage on shares of Anteris Technologies Global in a research note on Tuesday. They set an “overweight” rating and a $9.00 price target for the company. Barclays began coverage on shares of Anteris Technologies Global in a report on Tuesday. They set an “overweight” rating and a $22.00 price objective on the stock.

Anteris Technologies Global Trading Down 2.1 %

Shares of NASDAQ AVR opened at $5.63 on Tuesday. Anteris Technologies Global has a 1 year low of $5.10 and a 1 year high of $6.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.